Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
November 21, 2022
Study uncovers new proteins involved in regulating muscular dystrophy-linked gene
CRISPR-based proteomics technique reveals potential therapeutic targets for FSHD, a rare but devastating disease
DUX4 expressing cells R-N-A pickle
From the Tapscott Lab, Human Biology Division
Drs. Colleen Delaney, Harlan Robins named 2016 Leaders in Health Care
Celebrating faculty and staff achievements
Muscle or neuron? A simple swap can redirect cell fate
Alter just one section of the protein responsible for making a muscle cell a muscle cell — and it makes nerve cells instead
Glaxosmithkline partnership will target muscular dystrophy
Agreement merges Dr. Stephen Tapscott’s breakthrough research on facioscapulohumeral muscular dystrophy with drug-discovery expertise
Fred Hutch GSK Partnership - Fred Hutchinson Cancer Research Center
Collaboration represents first U.S. institution chosen to participate in GSK academic-industry partnership
Tapscott team finds two genetic flaws fuel form of muscular dystrophy
Latest in a series of breakthrough discoveries by the Fred Hutchinson Cancer Research Center’s Stephen Tapscott and an international team of researchers may lead to biomarker tests, new treatments